Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Adenocarcinoma and CHFR[original query] |
---|
CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer. International journal of cancer. Journal international du cancer 2011 Mar 128 (5): 1009-17. Koga Takaomi, Takeshita Masafumi, Yano Tokujiro, Maehara Yoshihiko, Sueishi Kats |
CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes. Human pathology 2013 Jul 44 (7): 1382-90. Koga Takaomi, Takeshita Masafumi, Ijichi Kayo, Yano Tokujiro, Maehara Yoshihiko, Sueishi Kats |
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2018 01 29 (1): 139-144. Overman M J, Adam L, Raghav K, Wang J, Kee B, Fogelman D, Eng C, Vilar E, Shroff R, Dasari A, Wolff R, Morris J, Karunasena E, Pisanic T R, Azad N, Kopetz |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: